620 related articles for article (PubMed ID: 11560997)
1. Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses.
Sutmuller RP; van Duivenvoorde LM; van Elsas A; Schumacher TN; Wildenberg ME; Allison JP; Toes RE; Offringa R; Melief CJ
J Exp Med; 2001 Sep; 194(6):823-32. PubMed ID: 11560997
[TBL] [Abstract][Full Text] [Related]
2. Generation of antitumor immunity by cytotoxic T lymphocyte epitope peptide vaccination, CpG-oligodeoxynucleotide adjuvant, and CTLA-4 blockade.
Davila E; Kennedy R; Celis E
Cancer Res; 2003 Jun; 63(12):3281-8. PubMed ID: 12810660
[TBL] [Abstract][Full Text] [Related]
3. Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation.
van Elsas A; Hurwitz AA; Allison JP
J Exp Med; 1999 Aug; 190(3):355-66. PubMed ID: 10430624
[TBL] [Abstract][Full Text] [Related]
4. Elucidating the autoimmune and antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: comparison of prophylaxis and therapy.
van Elsas A; Sutmuller RP; Hurwitz AA; Ziskin J; Villasenor J; Medema JP; Overwijk WW; Restifo NP; Melief CJ; Offringa R; Allison JP
J Exp Med; 2001 Aug; 194(4):481-9. PubMed ID: 11514604
[TBL] [Abstract][Full Text] [Related]
5. Depletion of CD25(+) CD4(+) T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon alpha-induced, CD8(+) T-cell-dependent immune defense of B16 melanoma.
Steitz J; Brück J; Lenz J; Knop J; Tüting T
Cancer Res; 2001 Dec; 61(24):8643-6. PubMed ID: 11751377
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) can regulate dendritic cell-induced activation and cytotoxicity of CD8(+) T cells independently of CD4(+) T cell help.
McCoy KD; Hermans IF; Fraser JH; Le Gros G; Ronchese F
J Exp Med; 1999 Apr; 189(7):1157-62. PubMed ID: 10190907
[TBL] [Abstract][Full Text] [Related]
7. Monotherapeutically nonactive CTLA-4 blockade results in greatly enhanced antitumor effects when combined with tumor-targeted superantigens in a B16 melanoma model.
Sundstedt A; Celander M; Eriksson H; Törngren M; Hedlund G
J Immunother; 2012 May; 35(4):344-53. PubMed ID: 22495392
[TBL] [Abstract][Full Text] [Related]
8. Induction of CTL responses by simultaneous administration of liposomal peptide vaccine with anti-CD40 and anti-CTLA-4 mAb.
Ito D; Ogasawara K; Iwabuchi K; Inuyama Y; Onoé K
J Immunol; 2000 Feb; 164(3):1230-5. PubMed ID: 10640735
[TBL] [Abstract][Full Text] [Related]
9. CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses.
Kingsley CI; Karim M; Bushell AR; Wood KJ
J Immunol; 2002 Feb; 168(3):1080-6. PubMed ID: 11801641
[TBL] [Abstract][Full Text] [Related]
10. A dual altered peptide ligand down-regulates myasthenogenic T cell responses by up-regulating CD25- and CTLA-4-expressing CD4+ T cells.
Paas-Rozner M; Sela M; Mozes E
Proc Natl Acad Sci U S A; 2003 May; 100(11):6676-81. PubMed ID: 12743364
[TBL] [Abstract][Full Text] [Related]
11. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.
Takahashi T; Tagami T; Yamazaki S; Uede T; Shimizu J; Sakaguchi N; Mak TW; Sakaguchi S
J Exp Med; 2000 Jul; 192(2):303-10. PubMed ID: 10899917
[TBL] [Abstract][Full Text] [Related]
12. Synergistic antitumor effect of chemotactic-prostate tumor-associated antigen gene-modified tumor cell vaccine and anti-CTLA-4 mAb in murine tumor model.
Li N; Qin H; Li X; Zhou C; Wang D; Ma W; Lin C; Zhang Y; Wang S; Zhang S
Immunol Lett; 2007 Nov; 113(2):90-8. PubMed ID: 17913245
[TBL] [Abstract][Full Text] [Related]
13. CTLA-4 blockade enhances the therapeutic effect of an attenuated poxvirus vaccine targeting p53 in an established murine tumor model.
Espenschied J; Lamont J; Longmate J; Pendas S; Wang Z; Diamond DJ; Ellenhorn JD
J Immunol; 2003 Mar; 170(6):3401-7. PubMed ID: 12626601
[TBL] [Abstract][Full Text] [Related]
14. Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity.
Shimizu J; Yamazaki S; Sakaguchi S
J Immunol; 1999 Nov; 163(10):5211-8. PubMed ID: 10553041
[TBL] [Abstract][Full Text] [Related]
15. Provision of granulocyte-macrophage colony-stimulating factor converts an autoimmune response to a self-antigen into an antitumor response.
Ji Q; Gondek D; Hurwitz AA
J Immunol; 2005 Aug; 175(3):1456-63. PubMed ID: 16034082
[TBL] [Abstract][Full Text] [Related]
16. CTLA-4 blockade enhances the CTL responses to the p53 self-tumor antigen.
Hernández J; Ko A; Sherman LA
J Immunol; 2001 Mar; 166(6):3908-14. PubMed ID: 11238635
[TBL] [Abstract][Full Text] [Related]
17. Targeted CTLA-4 engagement induces CD4+CD25+CTLA-4high T regulatory cells with target (allo)antigen specificity.
Vasu C; Prabhakar BS; Holterman MJ
J Immunol; 2004 Aug; 173(4):2866-76. PubMed ID: 15295006
[TBL] [Abstract][Full Text] [Related]
18. CD4 help-independent induction of cytotoxic CD8 cells to allogeneic P815 tumor cells is absolutely dependent on costimulation.
Zhan Y; Corbett AJ; Brady JL; Sutherland RM; Lew AM
J Immunol; 2000 Oct; 165(7):3612-9. PubMed ID: 11034363
[TBL] [Abstract][Full Text] [Related]
19. Tracking the immunoregulatory mechanisms active during allograft tolerance.
Sánchez-Fueyo A; Weber M; Domenig C; Strom TB; Zheng XX
J Immunol; 2002 Mar; 168(5):2274-81. PubMed ID: 11859115
[TBL] [Abstract][Full Text] [Related]
20. CTLA-4 engagement and regulatory CD4+CD25+ T cells independently control CD8+-mediated responses under costimulation blockade.
Coenen JJ; Koenen HJ; van Rijssen E; Boon L; Joosten I; Hilbrands LB
J Immunol; 2006 May; 176(9):5240-6. PubMed ID: 16621989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]